<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">In many cases, women face formal, legal barriers to harm reduction services that are not faced by men, at least not to the same extent. Key among these barriers are those placed in the way of pregnant or parenting women. Examples of this include clinical restrictions placed on women’s access to harm reduction services: for example, in Denmark pregnant women are the only group explicitly excluded from accessing drug consumption rooms, because of potential foetal harm, despite the greater potential harm of unsafe injection [
 <xref ref-type="bibr" rid="CR65">65</xref>, 
 <xref ref-type="bibr" rid="CR66">66</xref>]. In other cases, women can face criminal charges or a loss of parental rights for drug use while pregnant or parenting. These circumstances are not proven to deter drug use, but do imperil the relationship between women and health providers [
 <xref ref-type="bibr" rid="CR65">65</xref>]. The fear that children will be removed from their mother’s care if drug use is disclosed, or in some jurisdictions including in Russia and Ukraine, the risk of prosecution for child abuse or murder creates an even stronger deterrent to these women accessing harm reduction services [
 <xref ref-type="bibr" rid="CR14">14</xref>, 
 <xref ref-type="bibr" rid="CR16">16</xref>, 
 <xref ref-type="bibr" rid="CR18">18</xref>, 
 <xref ref-type="bibr" rid="CR21">21</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR67">67</xref>].
</p>
